KOSPI · Healthcare · ₩273B
₩16,400-2.38%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 1.8% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“개량신약 힘으로 수익성 회복의 발판을 만들었어요.”
In the company's words · 2026 2분기 filing